MONTREAL, March 31,
2022 /CNW/ - Lumiera Health
Inc. (TSXV: NHP) (the "Company" or
"Lumiera "), a company specializing in the development
and commercialization of natural health products, is pleased to
announce the expansion of its online distribution with the launch
of the company's Bazzzics™ line of natural sleep-aids on Amazon
Canada. The Company has also successfully listed Bazzzics™ on
Well.ca, one of Canada's leading
e-commerce retailer in the Health & Wellness sector.
"We launched Bazzzics™ Sleep Aids in January 2021 with limited retail distribution in
Quebec and announced our national
distribution agreement with Ecotrend in May 2021. We have
been building our retail distribution across Canada. We are
focused on further expanding our distribution so all Canadians
looking for natural solutions for better sleep can purchase
Bazzzics™. We are very happy to share that Bazzzics™ is now
available through Amazon.ca and Well.ca; two of Canada's biggest e-commerce retailers" says
Carlos Ponce, CEO of
Lumiera. "Expanding our online availability will help
us reach more Canadians, which will deliver incremental sales and
growth for Lumiera."
"There is more and more research that suggests our sleep
patterns are changing - we are getting less sleep every night
and our quality of sleep is poor. People are
looking for help and with our great products, we have a tremendous
opportunity to capitalize on the billions North Americans are
spending on sleep aids."
About
Bazzzics™ Natural Sleep Aids
Bazzzics™ is a unique line of three (3) products made from
plant-based active ingredients designed to be used alone or in
combination to address specific sleep issues.
Bazzzics™ PRE-SLEEP SERENITY Bazzzics Pre-Sleep Serenity helps
quiet the mind and calm the body during the evening,
Bazzzics™ FALL ASLEEP helps initiate the sleeping process to
fall asleep easily, and Bazzzics™ STAY ASLEEP facilitates
relaxation and reduces frequent awakenings so you can sleep until
morning.
For more information visit: bazzzics.ca
About Lumiera
Health
Lumiera specializes in the development and commercialization of
consumer products for the natural health industry. The Company
sells herbal tonics and natural supplements through its Holizen
Laboratories division, with a diverse portfolio including a line of
innovative sleep aids. The Company is also commercializing a unique
topical product line acting on the endocannabinoid system, without
the use of cannabis, that provides an innovative solution for
chronic pain and inflammation. A pioneer in the natural health
innovation space, the Lumiera brand is rooted in the core values of
science, nature and compassion. Our goal is to make people's
lives better by developing natural health and wellness products
that are effective, safe and trustworthy.
For more information visit: www.lumiera.ca.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-looking
information
Certain statements contained in this press release constitute
"forward-looking information" as such term is defined in applicable
Canadian securities legislation. The words "may", "would", "could",
"should", "potential", "will", "seek", "intend", "plan",
"anticipate", "believe", "estimate", "expect" and similar
expressions indicate such "forward-looking
information" as they relate to Lumiera. All statements other
than statements of historical fact may be forward-looking
information. Such statements reflect Lumiera' current views and
intentions with respect to future events, and current information
available to Lumiera, and are subject to certain risks,
uncertainties and assumptions. Such risks and uncertainties
include, among others, the risk factors included in Lumiera' annual
management's discussion and analysis for the year
ended November 30, 2020,
which is available under the issuer's SEDAR profile
at www.sedar.com. Material factors or assumptions
were applied in providing forward-looking information. Many factors
could cause the actual results, performance or achievements that
may be expressed or implied by such forward-looking information to
vary from those described herein should one or more of these risks
or uncertainties materialize. Should any factor affect Lumiera in
an unexpected manner, or should assumptions underlying the
forward-looking information prove incorrect, the actual results or
events may differ materially from the results or events predicted.
Any such forward-looking information is expressly qualified in its
entirety by this cautionary statement. Moreover, Lumiera does not
assume responsibility for the accuracy or completeness of such
forward-looking information. The forward-looking information
included in this press release is made as of the date of this press
release and Lumiera undertakes no obligation to publicly update or
revise any forward-looking information, other than as required by
applicable law.
Related Links: www.lumiera.ca
SOURCE Lumiera Health Inc.